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Background: In order to control and eradicate transboundary animal diseases, early diagnosis and reaction is essential
for the implementation of control activities. Thus, mobile diagnostic units which allow analytical testing close to the site
of occurrence could provide valuable support for centralized laboratories. Consequently, the availability of diagnostic
tests using mobile amplification and detection technologies has been increasing over the past years. However,
methods enabling rapid and simple nucleic acid extraction also under resource-limited settings are still scarce.
Methods: In the present study rapid extraction protocols based on magnetic particle technology have been
developed. For this purpose, the two open extraction platforms KingFisher™ Duo (Thermo Fisher Scientific) and
BioSprint® 15 (Qiagen) as well as the fully automated EZ1® advanced XL instrument (Qiagen) were used. All protocols
were validated in comparison to standard manual extraction using blood and serum samples from animals infected
with Schmallenberg virus or bovine viral diarrhea virus.
Results: All newly developed protocols allowed a complete extraction within 30 minutes of time. The fully automated
EZ1-extraction yielded the highest reproducibility, whereas slightly higher intra- and inter-assay variations were
observed using the open platforms. Compared to the manual procedure, the analytical sensitivity of all the rapid
protocols was 1 log10 step reduced for extraction from blood samples. For sera a reduced dynamic range could only
be observed using the maximally shortened BioSprint 15 protocol. Validation using clinical samples showed an
excellent concordance of all the rapid extraction protocols to the standard manual extraction procedure, independent
of sample materials and target viruses.
Conclusions: The results of this study show that the speed-optimized novel extraction protocols allow rapid and
simple nucleic acid extractions for a variety of target viruses without significant loss of sensitivity compared to standard
procedures. For this reason they represent valuable tools to accelerate magnetic particle based automated extraction.
Keywords: Nucleic acid extraction, Magnetic particle, Schmallenberg virus, Bovine viral diarrhea virus, Mobile
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Transboundary animal diseases, as e.g. Foot-and-Mouth
disease (FMD) and Classical swine fever (CSF) can have
serious socio-economic consequences for affected coun-
tries. Thus, early recognition and reaction to disease out-
breaks is essential to carry out control activities. In such
emergency situations, the set up of local disease control
centers as well as the use of mobile diagnostic units
would provide valuable support for centralized labo-
ratories. In addition, analytical testing close to the site* Correspondence: bernd.hoffmann@fli.bund.de
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unless otherwise stated.could circumvent the delays associated with the trans-
portation of samples and thus significantly reduce the
time to achieve a test result. This would enable a more
rapid local decision making which is crucial to prevent
further spreading of the disease. Consequently, over the
past years the availability of mobile molecular testing
systems has been increasing [1-5]. The most promising
developments provide fully automated sample-in/an-
swer-out analyses by combining nucleic acid extraction,
amplification and detection into one integrated system,
as e.g. the GeneXpert® by Cepheid [6,7], IQuum’s Liat™
Analyzer [8,9] or the Enigma® ML [10]. Other approaches
aimed to completely omit the nucleic acid extraction stepral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Speed-optimized extraction protocols for the KF
Duo and the BS 15 instrument
Step Reagents Timing of protocol steps (min)
Original KF Duo BS 15
Binding VXL + ACB + Beads 5 2 2
Wash 1 AW1 3 12 s 1
Wash 2 AW2 2 12 s 1
Wash 3 Ethanol 100% 2 12 s -
Evaporation Water 5 0 0
Elution AVE 2 1 0.5
Total time 24:00 8:00 7:50
Each step of the original protocol was shortened to the maximum for the
respective extraction platform.
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that are less prone to inhibition, allowing amplification of
target genes directly from crude samples. A variety of dir-
ect PCR assays have already been described and success-
fully applied [11-13]. However, the vast majority of the
available amplification and detection technologies require
off-line sample preparation and purification of the target
nucleic acids. [1,4,14]. For this purpose, a broad spectrum
of well validated manual and automated extraction tech-
nologies is already available. However, many of these me-
thods involve lengthy procedures that often have to be
performed by a trained technician. Alternatively, sophisti-
cated automated extraction robots allow high-throughput
analyses and significant reduction of hands-on time per
sample. Opposed to that, rapid and simple extraction pro-
tocols that can also be performed under resource-limited
settings, as e.g. directly in the field, are still scarce.
In the present study we aimed to establish rapid pro-
tocols which can be operated on various extractions
instruments and which can be easily adapted to a broad
spectrum of downstream assays. The protocols were devel-
oped using the two open extraction platforms KingFisher™
Duo (Thermo Fisher Scientific Inc.) and BioSprint® 15
(Qiagen) as well as the fully automated EZ1® Advanced XL
instrument (Qiagen). Optimization was performed for each
platform separately in order to reach the shortest possible
processing times while maintaining reliable and reprodu-
cible pathogen detection.
For the initial validation of the protocols two RNA vi-
ruses have been selected. Schmallenberg virus (SBV) is
an Orthobunyavirus from the family Bunyaviridae and
belongs to the Simbu serogroup [15,16]. Monitoring of
infected animals is performed in many countries inside
and outside of the European Union in order to increase
the knowledge on epidemiology and pathogenesis of this
newly emerging disease [17,18]. Bovine viral diarrhea
virus (BVDV) is classified as a member of the genus
Pestivirus within the family Flaviviridae [19]. It has been
shown before, that detection of persistently infected cattle
using rapid and simple test systems is a valuable tool in
BVD-eradication programs [20,21].
The performance of the speed-optimized extraction
protocols was further investigated with regard to the
efficiency of RNA recovery, reproducibility, as well as
analytical and diagnostic sensitivity. In addition, charac-
teristics like complexity, hands-on and total process-
ing time were evaluated in order to assess the suitability




Negative samples as well as all the SBV-positive blood
and serum samples were obtained during animal trials atthe Friedrich-Loeffler-Institut (FLI, Germany). All experi-
mental protocols were reviewed by a state ethics commis-
sion and have been approved by the competent authority
(State Office for Agriculture, Food Safety and Fisheries
of Mecklenburg-Vorpommern, Rostock, Germany, ref.
LALLF M-V TSD/7221.3-1.1-004/12). BVDV-positive
samples were kindly supplied by veterinary laboratories of
the German federal states. All samples were aliquoted and
stored at −20°C until further processing. Additional sam-
ples positive for classical swine fever virus (CSFV) and
bluetongue virus (BTV) were provided by the respective
national reference laboratories at the FLI.
Manual extraction
Manual extraction was performed using the QIAamp
Viral RNA Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s instructions. The input volume
was 100 μl for serum and 75 μl for blood samples. Ex-
tracted RNA was eluted in 100 μl of Buffer AVE.
Automated rapid extraction
Strategy
Rapid protocols were established on three magnetic par-
ticle based extraction instruments. This included (i) the
selection of suitable extraction reagents for all systems
and (ii) the design of maximally shortened extraction
protocols for the open extraction platforms.
A variety of extraction reagents commercially available
from Qiagen, Macherey-Nagel (Düren, Germany) and LSI/
life technologies (Lissieu, France) were comparatively eval-
uated in order to select the most suitable chemistry. For
this purpose, an established protocol for magnetic particle
based extraction was used (Original protocol, Table 1).
The BindIt Software v3.2 (Thermo Fisher) was used to
design protocols with the shortest possible processing
time for the two open extraction platform. For this pur-
pose, each step of the original protocol indicated in
Table 1, was shortened progressively to the maximum.
Evaluations were performed using SBV-positive blood
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specific and heterologous internal control RNA.
Extraction platforms
EZ1® Advanced XL (Qiagen, Hilden, Germany) The
EZ1 Advanced XL is a closed extraction system for up
to 14 samples using pre-filled reagent cartridges and
pre-programmed protocols. For extraction, the EZ1 DNA
Blood 200 μl kit (Qiagen) was used, but the reagents of
the supplied cartridges were exchanged with the following
buffers: binding buffer ACB, washing buffers AW1 and
AW2, and elution buffer AVE (Qiagen) [see Additional
file 1: Table S1]. For lysis, 200 μl of the sample material
were mixed with 200 μl of lysis buffer VXL (Qiagen) and
the lysate was loaded to the EZ1 instrument. Automated
extraction was then performed immediately using the EZ1
Advanced DNA Blood Card (Qiagen) which has a pro-
cessing time of 16 min. The extracted RNA was eluted
in 100 μl.
KingFisher™ Duo system (Thermo Fisher Scientific
Inc., Waltham, MA, USA) The KingFisher™ (KF) Duo
system was applied with a 12 pin magnet head which en-
abled processing of 12 samples per run using microtiter
96 deepwell plates (Thermo Fisher). Prior to the extrac-
tion process, the deepwell plates were filled with the fol-
lowing reagents: lysis buffer VXL, MagAttract Suspension
B, buffer AW1, buffer AW2 (Qiagen), 100% Ethanol (Carl
Roth GmbH, Karlsruhe, Germany), nuclease-free water
and buffer AVE (Qiagen) [see Additional file 1: Table S1].
For extraction, 100 μl of the sample were added to the
lysis buffer and mixed by pipetting. After that, binding
buffer ACB was added and automated extraction was
executed and completed within 8 min using the protocol
indicated in Table 1. The extracted RNA was eluted in
100 μl and subsequently transferred to 1.5 ml tubes for
storage.
BioSprint® 15 workstation (Qiagen) The BioSprint 15
(BS 15) workstation is an open extraction platform for
processing of up to 15 samples per run using 5-tube
plastic strips (Qiagen). The system is identical to the
KingFisher™ mL which is produced by Thermo Fisher
Scientific, Inc. The extraction was performed as des-
cribed before for the KF Duo using the respective pro-
tocol described in Table 1. For details on pre-filling
of 5-tube strips see Additional file 1: Table S1. The
total running time to complete the BS 15 extraction
was 7.5 min.
RT-qPCR
For RT-qPCR detection of SBV-RNA, a previously pub-
lished assay was used [22]. For the BVDV assay primers
Pesti-3F and Pesti-3R [23] were used in combinationwith the TQ-Pesti probe [24]. Detection of heterologous
internal control RNA was conducted as described before
[25]. All reactions were performed in a 12.5 μl volume
using the AgPath-ID™ One-Step RT-PCR kit (Applied
Biosystems, Carlsbad, CA, USA) according to the ma-
nufacturer’s instructions. RT-qPCR was performed on a
Bio-Rad CFX96 Real-Time Detection System (software
Bio-Rad CFX Manager 3.0; Bio-Rad, Hercules, CA, USA)
or on an Eco™ Real-Time PCR System (Eco™ software v4.0;
amplifa Labortechnik GmbH, Wasserburg, Germany)
using the following thermal profile: reverse transcrip-
tion for 10 min at 45°C, activation of polymerase for
10 min at 95°C, followed by 45 cycles of denaturation
for 15 s at 95°C, annealing for 20s at 56°C and elong-
ation for 30s at 72°C.Study design
(1) The relative sensitivity and the dynamic range of
the rapid extraction protocols were determined
using 10-fold dilution series of SBV- or BVDV-
positive blood and serum samples. Dilutions were
prepared in blood or serum tested negative for the
respective pathogen, aliquoted and stored at −20°C
until processing. For each extraction technique
duplicates of the different dilutions were extracted
in parallel. Due to the small volume of the provided
serum samples, two different BVDV-positive
samples had to be used (number 2 and number 9,
as indicated in Figure 1B).
(2) To assess the intra- and inter-run variation of each
extraction method, one SBV-RNA-positive EDTA
blood sample was extracted 6 times in each of three
independent runs.
(3) A panel of clinical samples was used to assess the
performance of the rapid extraction procedures in
comparison to the standard manual extraction
protocol. The panel consisted of 26 SBV-positive
(14× EDTA blood, and 12× serum) and 24 BVDV-
positive samples (12× EDTA blood, 12× serum).
Each sample was extracted once using the QIAamp
Virus Mini Kit and in duplicate with each of the
rapid automated protocols.
(4) BTV- and CSFV-positive samples were analyzed
using the BS 15 and the EZ1 to investigate the
suitability of the procedures for extraction of
additional target viruses.Statistical analysis
Regression analysis was used to assess the dynamic range
and the linearity of each extraction method. Pearson’s cor-
relation coefficient was calculated to compare the analy-
tical performance of both the automated and the manual
Figure 1 Analytical sensitivity and linear dynamic range of manual and rapid automated extraction methods. Dilution series of serum
samples positive for SBV-RNA (A) or BVDV-RNA (B) as well as dilution series of EDTA-blood samples positive for SBV-RNA (C) or BVDV-RNA (D)
were used to evaluate the extraction efficiency of the rapid extraction protocols in comparison to the standard manual extraction protocol. Each
dilution step was extracted in duplicate and the extracted RNA from each panel was tested in the same RT-qPCR run. R2 values as defined by
regression analysis are indicated for each method.
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by the parametric or non-parametric paired t-test in order
to assess differences in the extraction efficiency concern-
ing sample material and target virus. P-values ≤ 0.05 were
considered as significant. All analyzes were performed
using the SigmaPlot software v11. PCR efficiencies were
calculated from the slopes of standard curves indicated in
Figure 1 using the equation E = 10(−1/sope) – 1.Results
Selection of extraction reagents
In order to select an optimal chemistry, lysis buffers
from different commercially available extraction kits were
comparatively evaluated. Emphasis was set on the poten-
tial of the buffers to provide sample lysis at room tem-
perature without additional incubation time. Lysis buffer
VXL (Qiagen) outperformed the remaining candidates
with regard to these properties and was therefore se-
lected as a basis for the rapid extraction protocols.
Optimal lysis was obtained by using a 1:1 mixing ratio of
sample and buffer VXL. For serum and blood samples
volumes of 100 μl (KF Duo and BS 15) or 200 μl (EZ1)
proved to be optimal.Design of rapid extraction protocols
Since the EZ1 is a closed extraction system, modifica-
tion of extraction protocols by the user is not pos-
sible. Therefore, we selected the EZ1 Advanced DNA
Blood Card (Qiagen) for our experiments which pro-
vided the shortest processing time among the commer-
cially available protocols.
A standard protocol for magnetic particle based ex-
traction was used as basis for the KF Duo and BS 15
procedures. For both extraction platforms, the initial
binding step could be reduced from 5 min to 2 min. Fur-
thermore, the original ethanol evaporation step was re-
placed by a water rinse prior to elution of the extracted
RNA. Due to the different layouts of the extraction plat-
forms (96 well plates or 5-tube strips, respectively) the
washing times had to be optimized separately for the
KF Duo and the BS 15. For each platform the short-
est possible times which still guaranteed a reliable and
reproducible extraction have been determined. Whereas
the three washing steps of the KF Duo could be re-
duced to 12 s each, the two washing cycles of the BS
15 required processing times of 1 min in order to
guarantee reliable results (Table 1). Elution time was
found to be critical for reproducibility of the extraction
Table 3 PCR efficiency after manual and automated
extraction
Target Material % PCR efficiency
Manual EZ1 BS 15 KF Duo
SBV Blood 99.6 97.0 86.1 101.2
Serum 97.8 121.5 87.1 112.7
BVDV Blood 112.4 99.3 88.8 84.2
Serum 95.0 98.2 92.8 110.8
10-fold dilution series of SBV- and BVDV-positive blood and serum samples
which were extracted in duplicate; PCR efficiencies of the respective RNA
extracts were calculated from the slope of the standard curves.
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platform (Table 1).
Reproducibility
Reproducibility of the rapid extraction protocols and the
standard manual extraction was assessed using 6 repli-
cates of one SBV-positive blood sample in 3 independent
runs. Mean Cq-values as well as intra- and inter-assay
coefficients of variation are shown in Table 2. The high-
est reproducibility was found for the automated EZ1-
extractions, whereas the highest intra- and inter-assay
variations were observed for the BS 15.
Linearity and analytical sensitivity
The dynamic range of each extraction method was in-
vestigated using 10-fold dilution series of BVDV- or SBV-
positive blood and serum samples. For serum samples,
target RNA was detected over a concentration range of 5
log10 steps by manual, EZ1- and KF Duo-extraction. Using
the BS 15 the linear dynamic range covered only 4 log10
steps in case of SBV (Figure 1A, 1B). For blood samples,
the analytical sensitivity of all the rapid extraction proce-
dures was 1 log10 step reduced compared to the manual
extraction protocol (Figure 1C, 1D). Standard curves and
regression analysis revealed a linear response for all the in-
vestigated extraction techniques and excellent quantitative
parameters (Figure 1). Based on the slopes of standard
curves, the PCR efficiencies were calculated for the re-
spective RNA extracts (Table 3). The EZ1- and KF Duo-
extracts yielded similar or even higher PCR efficiencies
than the concordant manually extracted samples. A re-
duction in PCR efficiency was observed for all BS 15-
extractions, independent of sample material and target
virus, as well as for the extraction of BVDV-RNA from
blood using the KF Duo (Table 3).
Clinical samples and correlation with manual extraction
The performance of the rapid extraction procedures in
comparison to manual extraction was further evaluated
using blood and serum samples from animals experimen-





SD CV% SD CV%
Manual 23.83 0.19 0.80 0.14 0.58
EZ1 24.10 0.16 0.65 0.12 0.51
BS 15 25.12 0.34 1.36 0.28 1.10
KF Duo 25.31 0.25 1.00 0.20 0.79
SD = standard deviation, CV = coefficient of variation.
Mean Cq values, standard deviations of replicates as well as intra- and
inter-assay coefficients of variation were defined using 6 replicates of an
SBV-positive blood sample in 3 independent runs.EZ1-extraction (Figure 2A) of SBV-RNA showed a very
good correlation to the manual procedure (r = 0.95) with
an average difference of Cq-values (ΔCq) of −1.08 (stand-
ard deviation SD 0.98). For extraction of BVDV-RNA
the ΔCq was −0.65 (SD 0.98) with a total correlation co-
efficient of 0.96. Extractions on the BS 15 (Figure 2B)
yielded a very good correlation to manual extraction for
SBV (r = 0.96) and BVDV (r = 0.97) with correspond-
ing ΔCq values of −1.31 (SD 0.83) and −0.92 (SD 0.86),
respectively. Using the KF Duo protocol (Figure 2C),
the total correlation to manually extracted samples was
slightly better for SBV-RNA (r = 0.96) compared to
BVDV-RNA (r = 0.94) which corresponds to ΔCq values
of −1.25 (SD 0.71) for SBV and −1.6 (SD 1.11) for BVDV.
For all procedures, extraction of target RNA was equally
efficient from blood and serum samples.
Using the BS 15 and the EZ1, BVDV-RNA was recov-
ered with a significantly higher correlation to the manual
extraction than SBV-RNA (P < 0.05). For all samples ex-
tracted on the KF Duo heterologous internal control
(IC) RNA was added to the lysates and extracted in
order to gain additional insights into the quality of the
purification process. After manual extraction, IC-RNA
was detected in blood and serum samples with a mean
Cq-value of 27.7 (SD 1.09) or 26.6 (SD 0.36), respect-
ively, Using the KF Duo, the mean Cq-value was 29.6
(SD 1.28) for blood samples and 27.9 (SD 0.6) in case of
serum samples.
In order to investigate the suitability of the EZ1- and
the BS 15-protocol for extraction of different target vi-
ruses, BTV- and CSFV-positive samples were also ana-
lyzed. Using BTV-positive blood samples, a very good
correlation to manual extraction could be found for
both, the EZ1 (r = 0.95) and the BS 15 (r = 0.98) [see
Additional file 2: Figure S1]. Similar results were ob-
tained for CSFV-positive serum samples. Even though
the analytical sensitivity was 1 log10 step reduced using
the rapid protocols, r-values of 1.00 for the EZ1 and 0.98
for the BS 15 again indicated an excellent concordance
with the manual extraction protocol [see Additional file 3:
Figure S2].
Figure 2 Analytical performance of rapid automated extraction using clinical samples. Direct comparison of standard manual extraction
with automated extraction procedures using the EZ1 Advanced XL (A), the BS 15 (B), and the KF Duo (C). For this purpose, blood and serum
samples positive for SBV-RNA (black circles) or BVDV-RNA (white circles) were used. Regression is indicated by solid lines for SBV-positive samples
and by dashed lines for BVDV-positive samples.
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processing time
The hands-on and total processing time of each ex-
traction method was measured using a set of 8 samples
(Table 4). The total hands-on time required to perform
each step of the extraction procedure was about 16 min
for the KF Duo and the BS 15, which included the time
used for filling deepwell plates or tube strips. Thus, to-
gether with an instrument running time of about 8 min,
one extraction run could be completed within 25 min.Table 4 Operational analysis of manual and automated
extraction procedures
Operator step Required operator time (minutes)
Manual EZ1 BS 15 KF Duo
Filling of reagents 5a 15 5 5
Mix sample + lysis buffer 10 5 10 10
Incubation 10 0 0 0
Load instrument 0 5 1 1
Extraction/Instrument run 30 16 7.5 8
Total hands-on time 40 - 45 25 16 16
Total processing time 50 - 55 41 24 24
adissolving carrier RNA.
The time required for each operator step was measured for the extraction of 8
samples, respectively.In order to reduce the total processing time to 20 min,
pre-filled and sealed deepwell plates or tube strips could
be used. Using the EZ1, 41 min were required for the
extraction of 8 samples. However, the main part of the
25 min hands-on time was needed to empty and re-fill
the reagent cartridges. By using pre-filled cartridges, which
contain all necessary reagents, the extraction process
could be reduced to less than 30 minutes.
Discussion
Over the past years, the demands for rapid and simple
diagnostic tests which can be performed outside of a cen-
tralized laboratory have been increasing. However, despite
the increasing availability of innovative mobile amplifi-
cation and detection technologies, the sample processing
step remains an important bottleneck in these develop-
ments. In the present study we established rapid extrac-
tion protocols which can be operated on different portable
extraction instruments. The protocols were optimized
in order to reach the shortest possible processing times
which still allowed reproducible and reliable pathogen
detection.
Among a variety of extraction reagents from different
suppliers, we selected the lysis buffer VXL (Qiagen) as a
basis for our extraction protocols because it promoted
efficient cell lysis without any incubation time simply by
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tion of binding buffer ACB (Qiagen) to the lysate further
enabled a very rapid binding of the extracted nucleic
acids to the magnetic particles. Since it does not require
any additional equipment, as e.g. a heating block, the me-
thod is suitable for application under resource-limited set-
tings in emergency situations. It further represents an
attractive tool to decrease the processing time of magnetic
particle based extractions also in the laboratory routine.
The KF Duo protocol can be applied without further mo-
dification on similar platforms with higher capacity, as e.g.
the KingFisher™ Flex system (Thermo Fisher). Thus, ex-
traction of up to 96 samples could be completed in less
than 30 min of time.
The intra- and inter-assay variations of the rapid ex-
traction protocols were found to be in the same range as
those of a standard extraction method. This indicates
that a reliable and reproducible nucleic acid extraction is
possible despite a marked shortening of the whole purifi-
cation procedure. Due to the fully automated and stan-
dardized working process, the lowest variability was found
for the EZ1-extraction. Slightly higher intra- and inter-
assay variations were observed for the two open extraction
platforms, most likely since these systems required more
user input and manual pipetting steps. It was further seen,
that the KF Duo performed better than the BS 15, which
might be associated with the additional Ethanol-washing
step included in the KF Duo protocol made possible by
the use of 96 well deepwell plates for extraction.
Using dilution series of RNA-positive samples, the ra-
pid extraction protocols yielded a high accuracy and
linearity compared to the “gold standard” manual pro-
cedure. However, differences could be observed between
the individual systems. Extraction on the BS 15 caused a
reduction in PCR efficiency independent of the applied
sample material and thus showed the lowest analytical
sensitivity among the three evaluated methods. This can
be associated with the shortening of the washing process
to only 2 steps opposed to the 3 steps included in the
EZ1- and the KF Duo-protocol. However, the latter two
protocols revealed variations in extraction efficiency de-
pendent on the specimen used for extraction. From se-
rum samples, RNA could be recovered over the same
dynamic range as with the standard manual extraction
protocol. In contrast, the analytical sensitivity was one
log10 step reduced for blood, a fact which could be ex-
plained with a high content of PCR inhibitory substances
[26,27]. Most likely, the inhibitors cannot be completely
removed from the final RNA extracts using the shorter
purification procedures. Thus, residues of these substan-
ces could interfere with the subsequent PCR amplifi-
cation step of the target genome resulting in a negative
influence on the test sensitivity. Accordingly, monitoring
of internal control RNA during KF Duo extraction showedan inferior quality of the RNA extraction compared to the
standard manual procedure. In order to investigate the
relevance of these findings for a future field-use, clinical
samples from naturally as well as experimentally infected
animals were analyzed. Independent of the sample mater-
ial and its quality, the three rapid extraction techniques
yielded an excellent correlation with the selected standard
manual procedure. Hence, the slightly inferior analytical
sensitivity and extraction quality described above are not
critical with regard to a point-of-care application since
clinically diseased animals with high genome copy num-
bers of the respective pathogens are the main targets.
Using the EZ1 and the BS 15, RNA extraction was
more efficient for BVDV than for SBV, independent of
the applied sample material. This finding might indicate
that the non-segmented BVDV-genome is easier to re-
cover than the tripartite SBV-genome using the short ex-
traction procedures. The suitability of the rapid protocols
for extraction of different target viruses was therefore in-
vestigated in more detail by testing additional BTV- and
CSFV-positive samples. In accordance to the results ob-
tained for SBV and BVDV, an excellent correlation to the
manual extraction procedure could be demonstrated for
both, the EZ1- and the BS 15-protocol. This implies that
the newly developed protocols can be applied for a broad
range of downstream assays without further adaptations
dependent on the target virus. Thus, simultaneous screen-
ing for different pathogens can be performed after a single
preparation step. However, with regard to practicability of
these techniques, there are several important factors to
consider besides their analytical performance. This in-
cludes complexity of operation, hands-on time, total pro-
cessing time as well as necessary technical skills of the
operator.
Using the EZ1 demonstrated that a closed extraction
system could result in a markedly reduced hands-on
time. Except for the initial mixing of the sample with the
lysis buffer, all pipetting steps are automatically performed
by the instrument, which allows a high standardization.
However, to enable extraction of viral RNA using the EZ1
Advanced DNA Blood Card we had to use the card in
combination with modified reagent cartridges that are not
commercially available. Thus, a successful application of
the EZ1 in a rapid extraction protocol is dependent on the
supply of suitable extraction kits by the manufacturer. In
our view, this lack of flexibility represents a significant
drawback of the closed system. Since the instrument can
only be operated with pre-programmed cards and accom-
panying kits, its use is limited to specified applications and
associated with relatively high costs per reaction.
Contrary, flexibility is the most attractive feature of the
open extraction platforms, i.e. the protocols can easily be
modified and adapted to a broad range of applications and
pathogens. Furthermore, chemistries can be freely selected
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and a reduction of costs per reaction. Even though we
used buffers VXL and ACB as a basis, the presented pro-
tocols could also be operated and validated using similar
extraction reagents from other suppliers. In comparison
to the EZ1, the KF Duo and the BS 15 required more dir-
ect user-input. This included several operator steps like
pre-filling of deepwell plates or tube-strips, preparation of
lysates, addition of binding buffer, or transfer of extracted
RNA to storage tubes. Hence, a certain degree of technical
skills is required for the operation and the risk of human
errors and contaminations is comparatively higher than
with a closed system. However, an additional advantage of
the KF Duo and the BS 15 is the relatively small size and
low weight of the instruments (16 kg and 10 kg, respec-
tively). For the EZ1, which has a weight of about 50 kg,
transportation and operation in a car might be more
challenging.
Conclusion
In the present study, three rapid automated extraction
protocols were developed and validated. Using two open
platforms provided the possibility to freely adapt chemis-
try and to design protocols with a minimum processing
time. In contrast, the fully automated EZ1 system re-
quired a minimum of hands-on time, showed a high reli-
ability and a reduced risk of contamination. The newly
developed protocols allowed nucleic acid extraction in
less than 30 min and showed excellent concordance with
a standard manual extraction protocol. For this reason,
they represent valuable tools for rapid sample processing
under emergency settings as well as for the acceleration
of magnetic particle based extractions in the routine la-
boratory diagnostic.
Additional files
Additional file 1: Table S1. Reagents and filling scheme for rapid
automated extraction protocols. Detailed list of the reagents and the
volumes used to prefill deepwell plates or 5-tube strips for extraction
on the KF Duo and the BS 15, as well as reagents used to create the
proprietary reagent cartridges for EZ1 extraction.
Additional file 2: Figure S1. Evaluation of EZ1- and BS 15-extraction
using BTV-positive samples. 8 BTV-positive blood samples covering
serotypes 2, 4 and 8 were extracted with each extraction technique and
directly compared to the standard manual extraction protocol. The
corresponding regression lines are indicated solid for the EZ1 and dashed
for the BS15.
Additional file 3: Figure S2. Evaluation of EZ1- and BS 15-extraction
using CSFV-positive samples. A dilution series of a CSFV-positive serum
sample was extracted in triplicate with each extraction technique and in
comparison with the standard manual procedure. Results of linear
regression analysis are indicated for each method.
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